Clinical and Economic Efficacy of Fixed-dose Combination Indacaterol/Glycopyrronium Bromide in Patients with Chronic Obstructive Pulmonary Disease
Clinical and economic assessment of the efficacy of new drugs for the treatment of chronic obstructive pulmonary disease is very important because of social and economic burden of the disease. The study was aimed to assess clinical and economic efficacy of fixed-dose combination indacaterol/glycopyrronium bromide in comparison with conventional therapy in real clinical practice. Epidemiological study was conducted in different regions of Russia.